These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28429777)

  • 1. Interleukin-6 increases the expression and activity of insulin-degrading enzyme.
    Kurauti MA; Costa-Júnior JM; Ferreira SM; Santos GJ; Sponton CHG; Carneiro EM; Telles GD; Chacon-Mikahil MPT; Cavaglieri CR; Rezende LF; Boschero AC
    Sci Rep; 2017 Apr; 7():46750. PubMed ID: 28429777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Exercise Improves Insulin Clearance and Increases the Expression of Insulin-Degrading Enzyme in the Liver and Skeletal Muscle of Swiss Mice.
    Kurauti MA; Freitas-Dias R; Ferreira SM; Vettorazzi JF; Nardelli TR; Araujo HN; Santos GJ; Carneiro EM; Boschero AC; Rezende LF; Costa-Júnior JM
    PLoS One; 2016; 11(7):e0160239. PubMed ID: 27467214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
    Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exercise restores insulin clearance in diet-induced obese mice.
    Kurauti MA; Costa-Júnior JM; Ferreira SM; Dos Santos GJ; Protzek AO; Nardelli TR; de Rezende LF; Boschero AC
    J Endocrinol; 2016 Jun; 229(3):221-32. PubMed ID: 27000684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.
    González-Casimiro CM; Cámara-Torres P; Merino B; Diez-Hermano S; Postigo-Casado T; Leissring MA; Cózar-Castellano I; Perdomo G
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
    Abdul-Hay SO; Kang D; McBride M; Li L; Zhao J; Leissring MA
    PLoS One; 2011; 6(6):e20818. PubMed ID: 21695259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.
    Wei X; Ke B; Zhao Z; Ye X; Gao Z; Ye J
    PLoS One; 2014; 9(4):e95399. PubMed ID: 24740421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme.
    Protzek AO; Rezende LF; Costa-Júnior JM; Ferreira SM; Cappelli AP; de Paula FM; de Souza JC; Kurauti MA; Carneiro EM; Rafacho A; Boschero AC
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):1-8. PubMed ID: 26386462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice.
    Rezende LF; Camargo RL; Branco RC; Cappelli AP; Boschero AC; Carneiro EM
    Br J Nutr; 2014 Sep; 112(6):900-7. PubMed ID: 25036874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits.
    Borges DO; Patarrão RS; Ribeiro RT; de Oliveira RM; Duarte N; Belew GD; Martins M; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Raposo JF; Jones JG; Penha-Gonçalves C; Macedo MP
    Metabolism; 2021 May; 118():154735. PubMed ID: 33631143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.
    Kulas JA; Franklin WF; Smith NA; Manocha GD; Puig KL; Nagamoto-Combs K; Hendrix RD; Taglialatela G; Barger SW; Combs CK
    Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E106-E120. PubMed ID: 30422705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.
    Villa-Pérez P; Merino B; Fernández-Díaz CM; Cidad P; Lobatón CD; Moreno A; Muturi HT; Ghadieh HE; Najjar SM; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2018 Nov; 88():1-11. PubMed ID: 30098324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats.
    Elseweidy MM; Amin RS; Atteia HH; Ali MA
    Biomed Pharmacother; 2017 Jan; 85():155-159. PubMed ID: 27930980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice.
    Vettorazzi JF; Kurauti MA; Soares GM; Borck PC; Ferreira SM; Branco RCS; Michelone LSL; Boschero AC; Junior JMC; Carneiro EM
    Sci Rep; 2017 Nov; 7(1):14876. PubMed ID: 29093479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of insulin-degrading enzyme leads to mice testicular morphological changes and impaired sperm quality.
    Meneses MJ; Borges DO; Dias TR; Martins FO; Oliveira PF; Macedo MP; Alves MG
    Mol Cell Endocrinol; 2019 Apr; 486():11-17. PubMed ID: 30807788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice.
    Merino B; Fernández-Díaz CM; Parrado-Fernández C; González-Casimiro CM; Postigo-Casado T; Lobatón CD; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2020 Dec; 113():154352. PubMed ID: 32916153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term High-Fat Diet Decreases Renal Insulin-Degrading Enzyme Expression and Function by Inhibiting the PPARγ Pathway.
    Su Q; Huang J; Chen X; Wang Y; Shao M; Yan H; Chen C; Ren H; Zhang F; Ni Y; Jose PA; Zhong J; Yang J
    Mol Nutr Food Res; 2023 Apr; 67(7):e2200589. PubMed ID: 36726048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing.
    Brandimarti P; Costa-Júnior JM; Ferreira SM; Protzek AO; Santos GJ; Carneiro EM; Boschero AC; Rezende LF
    J Endocrinol; 2013 Nov; 219(2):173-82. PubMed ID: 23959080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of mPer2 increases plasma insulin levels by enhanced glucose-stimulated insulin secretion and impaired insulin clearance in mice.
    Zhao Y; Zhang Y; Zhou M; Wang S; Hua Z; Zhang J
    FEBS Lett; 2012 May; 586(9):1306-11. PubMed ID: 22504074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.